With respect to the liver, recent reports have shown that carriers of the PNPLA3 p.I148M variant (i.e., the main genetic determinant of non-alcoholic fatty liver disease) have impaired kidney function [65]; however, the mechanisms linking hepatic steatosis with a worse renal function are still partially unknown. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.